This website uses cookies to improve your experience. You can accept or reject analytics cookies
Protocolo de Atención de Problemas Médicos más Frecuentes en Adultos
Public HealthHealth Guideline2010
NicaraguaSpanishPDF
National
AI-Generated Document Summary
Objectives
This Ministry of Health protocol provides a standardised framework for assessing, diagnosing and treating common adult medical conditions that contribute substantially to morbidity and mortality. It aims to support free, safe, efficient, compassionate and high-quality care without refusing demand, while linking services across the health network for prevention, assessment, control, rehabilitation and follow-up.
Standardise clinical criteria and reduce unjustified variation in management, improving rational use of available personnel and medical supplies without compromising quality or humane care.
Apply protocol standards to health personnel caring for adults in public and private hospital establishments, particularly adults requiring hospital care for the covered medical problems.
Reduce adverse outcomes from acute coronary syndrome by relieving ischaemic pain and anxiety, stabilising haemodynamics, restoring coronary blood flow promptly, reducing myocardial oxygen demand, managing complications and improving prognosis.
Improve cerebrovascular disease outcomes through early diagnosis, reduced neurological consequences, prevention and treatment of complications, risk-factor modification, secondary prevention and rehabilitation.
Preserve life during asthma exacerbations by rapidly reducing airway resistance, improving gas exchange, correcting significant hypoxaemia, relieving obstruction and reducing inflammation.
The protocol combines broad service-quality objectives with condition-specific emergency care priorities. These include distinguishing hypertensive urgency from emergency according to acute target-organ damage, stabilising and transferring patients who require higher-level care, applying timely diagnostic tests, and tailoring treatment intensity to clinical severity.
Implementation
Implementation is based on nationally standardised clinical protocols developed by teams from Hospital Alemán Nicaragüense and Hospital Escuela Antonio Lenin Fonseca, reviewed by the Ministry of Health and compared with internationally published evidence and guidance. Technical review, expert review at national referral hospitals, validation through Local Health Systems, and approval by the Health Sector Standards and Protocols Approval Commission form the stated governance and quality-assurance pathway.
Deliver care through a tiered network in which primary-care or lower-resolution facilities provide initial assessment, stabilisation and treatment, then transfer patients with severe or complex presentations to higher-level facilities.
Use hospital, coronary-care or intensive-care settings for conditions requiring continuous monitoring, intravenous treatment, advanced respiratory support, invasive procedures or specialist management.
Assess hypertensive crises through history, treatment adherence, bilateral blood-pressure measurement, examination and evaluation for acute target-organ damage; manage urgency through observation and oral treatment where appropriate, while treating emergencies with monitored intravenous therapy and hospital admission.
Provide acute coronary syndrome treatment immediately at any level of care, including stabilisation, oxygenation assessment, antiplatelet and anticoagulant treatment where indicated, and prompt reperfusion for eligible patients with persistent ST-segment elevation or left bundle branch block.
Assess suspected cerebrovascular disease urgently through neurological examination, non-contrast brain computed tomography and supporting laboratory and cardiac investigations, as clinical features alone cannot reliably distinguish infarction from haemorrhage.
Provide supportive cerebrovascular care through airway and oxygen support, cardiac monitoring where available, cautious fluid and glucose management, pressure-ulcer prevention, urinary care, hyperthermia management and early rehabilitation once haemodynamic stability is achieved.
Manage convulsive status epilepticus in emergency or intensive-care settings by maintaining the airway, obtaining intravenous access, monitoring vital signs and cardiac rhythm, terminating seizures rapidly, preventing recurrence, treating underlying causes and managing complications.
Stabilise upper gastrointestinal haemorrhage through haemodynamic assessment, intravenous access, fluid replacement, oxygen and transfusion when indicated, followed by endoscopy for diagnosis, prognosis and haemostasis after haemodynamic recovery.
Manage variceal bleeding with cautious volume replacement, airway protection where aspiration risk exists, infection management, temporary pharmacological or balloon-tamponade haemostasis where necessary, and definitive procedures in experienced, appropriately equipped facilities.
Classify acute pancreatitis using clinical, biochemical and imaging findings, assess severity with recognised criteria, provide fasting, individualised intravenous fluid replacement, analgesia and metabolic management, and restrict antibiotic prophylaxis to specified severe presentations.
Manage community-acquired pneumonia empirically at first, adapt antimicrobial therapy when microbiological findings permit, and determine outpatient, ward or intensive-care treatment using severity assessment, including CURB-65 and intensive-care criteria.
Assess asthma severity using clinical features, pulse oximetry and forced expiratory volume in one second or peak expiratory flow where feasible; treat mild episodes in the community, urgently transfer non-responsive cases, and use oxygen, repeated inhaled bronchodilators and early systemic glucocorticoids for moderate-to-severe attacks.
Operational accountability is assigned to health-service establishments and the Local Systems for Comprehensive Health Care, known as SILAIS. Establishments are to apply the protocols and submit monthly compliance reports to the relevant SILAIS Department of Health Services; SILAIS directorates are to supervise public and private providers through visits and monthly indicator review.The principal stated indicator is the percentage of sampled patient records meeting basic protocol standards for identification of the medical problem, appropriate diagnostic studies and pharmacological treatment. It is calculated as compliant records divided by examined records, multiplied by 100, with an expected value of 100%; twenty records are reviewed monthly and verified through a record-review report.
The protocol also embeds condition-specific clinical monitoring, such as blood-pressure reassessment during hypertensive treatment, electrocardiography soon after arrival for suspected acute coronary syndrome, neurological and physiological observation for cerebrovascular events, and monitoring of response to respiratory treatment in pneumonia and asthma.The document was prepared in September 2010, scheduled for review in September 2012, and envisages Ministry of Health updates using evidence-based medicine, with suggestions submitted to the General Directorate of Sanitary Regulation.
Monitoring & Evaluation
The protocol combines document-level compliance monitoring with condition-specific bedside assessment and follow-up. Its formal accountability mechanism requires monthly reporting and supervisory review through Local Systems for Comprehensive Health Care (SILAIS), while most clinical sections specify monitoring parameters and treatment targets but not condition-specific reporting or surveillance systems.
Measure compliance with basic adult medical protocol standards, covering identification of the medical problem, appropriate diagnostic studies and pharmacological treatment where applicable.
Calculate compliance as the percentage of sampled patient records meeting all basic standards, with an expected value of 100%.
Review 20 clinical records each month, document findings in a record-review report, and submit monthly compliance reports from health-service establishments to the relevant SILAIS Department of Health Services.
Conduct supervisory visits and monthly reviews of indicator reports through each SILAIS Directorate across public and private providers in its territory.
Maintain document quality assurance through technical review, expert review, validation through Local Health Systems, approval by the Health Sector Standards and Protocols Approval Commission, and Ministry of Health-led updating using evidence-based medicine. The protocol was prepared in September 2010 and scheduled for review in September 2012.
For hypertensive crises, monitoring centres on blood pressure, symptoms and target-organ damage to distinguish urgency from emergency.Hypertensive urgency management includes blood-pressure measurement 30 minutes after treatment and observation for 6 to 12 hours where pressure remains elevated or treatment is modified.Emergency management requires hospital monitoring, preferably in intensive care, with a target reduction in diastolic pressure of 10% to 15% or to 110 mmHg within 30 to 60 minutes; aortic dissection requires systolic pressure below 120 mmHg within 5 to 10 minutes.
For acute coronary syndrome, early electrocardiography within 5 to 10 minutes of hospital arrival is identified as a service-quality measure.Clinical assessment uses electrocardiographic changes, cardiac markers, haemodynamic status, recurrent ischaemia and arrhythmia to determine risk and treatment pathways.Troponin testing at admission and 12 hours later, with stress testing before or after discharge where both results are normal, supports clinical follow-up.During unfractionated heparin infusion, activated partial thromboplastin time is to be maintained between 50 and 70 seconds for 48 hours.
Cerebrovascular care relies on repeated neurological, haemodynamic, respiratory, cardiac, glucose and fluid-balance assessment.The protocol calls for electrocardiography at admission and 24 hours, continuous cardiac monitoring where available, and glucose testing at intervals determined by glucose levels, with no more than six hours between tests during the first 24 hours.Thrombolysis requires intensive blood-pressure monitoring for 24 hours after treatment begins, while mannitol treatment requires plasma-osmolarity monitoring and ticlopidine requires haematological monitoring every two weeks for three months.
Other acute conditions use defined clinical measurements and prognostic classifications rather than programme-level performance systems. Upper gastrointestinal haemorrhage management includes monitoring vital signs at least every four hours, haematocrit every 12 hours, urine output, systolic blood pressure and pulse.Acute pancreatitis assessment uses Ranson criteria during admission and the first 48 hours, computed-tomography grading, organ failure and local complications to determine severity.Community-acquired pneumonia uses CURB-65 and intensive-care criteria to inform treatment location.Asthma management monitors oxygen saturation, forced expiratory volume in one second or peak expiratory flow, ventilatory-failure signs and response to treatment.
Across the supplied clinical sections, the protocol generally does not specify disease-specific reporting schedules, surveillance systems, audit arrangements, population-level outcome targets or formal accountability mechanisms beyond the overarching monthly compliance indicator and SILAIS supervision.
Costing & Financing
Financial information is limited. The protocol frames adult medical care as free and seeks efficient use of available health personnel and medical supplies without compromising quality, but it provides no overall budget, expenditure plan, funding source, resource-mobilisation strategy, funding gap or quantified economic assumptions.
Provide free adult medical services using available health personnel and medical supplies.
Recognise that upper gastrointestinal haemorrhage contributes to substantial healthcare costs and work absenteeism, although no monetary estimate is provided.
Require clinical resources including medicines, laboratory testing, imaging, monitoring, intravenous fluids, oxygen, blood products, intensive care, specialised procedures and trained staff across the covered conditions, without costing these inputs.
Note that continuous cardiac monitoring and higher-acuity insulin infusion depend on resource availability in cerebrovascular care, but the document does not quantify equipment, staffing or operating costs.
No prices, unit costs, allocations, financing mechanisms or economic evaluations are supplied for hypertensive crises, acute coronary syndrome, cerebrovascular disease, seizures, gastrointestinal haemorrhage, pancreatitis, pneumonia or asthma.